⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10332679 | 0.71 | — | — | |
| SCHEMBL355884 | 0.71 | — | — | |
| SCHEMBL3263265 | 0.67 | — | — | |
| SCHEMBL15628901 | 0.60 | — | — | |
| SCHEMBL19935 | 0.59 | — | — | |
| SCHEMBL25300799 | 0.58 | — | — | |
| SCHEMBL11670125 | 0.58 | — | — | |
| SCHEMBL6258387 | 0.58 | — | — | |
| SCHEMBL166729 | 0.58 | — | — | |
| SCHEMBL28760906 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210324169-A1 | ENGINEERING A POROUS CONDUCTIVE PEDOT:PSS-DVS SCAFFOLD FOR MICROBIAL FUEL CELL AIR CATHODES | NORTHEASTERN UNIVERSITY | 2021-10-21 | — | — | US | disclosed |
| US-9504640-B2 | Modified release formulations of a bupropion salt | VALEANT PHARMACEUTICALS LUXEMBOURG S.Á.R.L. (LU) | 2016-11-29 | — | — | US | disclosed |
| US-20150202147-A1 | Modified Release Formulations Of A Bupropion Salt | VALEANT INTERNATIONAL BERMUDA (BM) | 2015-07-23 | — | — | US | disclosed |
| US-8932628-B2 | Modified release formulations of a bupropion salt | VALEANT INTERNATIONAL BERMUDA (BM) | 2015-01-13 | — | — | US | disclosed |
| US-20140242063-A1 | PHARMACEUTICAL COMPOSITIONS | VALEANT LABORATORIES INTERNATIONAL BERMUDA (BM) | 2014-08-28 | — | — | US | disclosed |
| US-20140170216-A1 | BUPROPION HYDROBROMIDE POLYMORPHS | VALEANT INTERNATIONAL BERMUDA (BM) | 2014-06-19 | — | — | US | disclosed |
| US-20140030249-A1 | Pharmaceutical Compositions | VALEANT INTERNATIONAL BERMUDA (BM) | 2014-01-30 | — | — | US | disclosed |
| US-8604085-B2 | Bupropion hydrobromide polymorphs | VALEANT INTERNATIONAL BERMUDA (BM) | 2013-12-10 | — | — | US | disclosed |
| US-20130266650-A1 | BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS | JACKSON GRAHAM (BB) | 2013-10-10 | — | — | US | disclosed |
| US-20130059005-A1 | BUPROPION HYDROBROMIDE POLYMORPHS | JPMORGAN CHASE BANK, N.A. | 2013-03-07 | — | — | US | disclosed |
| US-5603953-A | HYDROPHILIC MATERIAL SURROUNDED BY MICROPOROUS SUPPORTING WALL HAVING HYDROPHOBIC LIQUID ENTRAINED IN PORES, WITH VARIABLE WATER PERMEABILITY, FOR CONTROLLED DRUG DELIVERY | PFIZER INC. (US) | 1997-02-18 | — | — | US | disclosed |
| EP-0711146-A1 | OSMOTIC DEVICES HAVING VAPOR-PERMEABLE COATINGS | PFIZER INC. (US) | 1996-05-15 | — | — | EP | disclosed |
| EP-0670717-A1 | SUPPORTED LIQUID MEMBRANE DELIVERY DEVICES | PFIZER INC. (US) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995003033-A1 | OSMOTIC DEVICES HAVING VAPOR-PERMEABLE COATINGS | PFIZER INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| US-5358502-A | PH-triggered osmotic bursting delivery devices | PFIZER INC (US) | 1994-10-25 | — | — | US | disclosed |
| EP-0612520-A2 | PH-triggered osmotic bursting delivery devices | PFIZER INC. (US) | 1994-08-31 | — | — | EP | disclosed |
| WO-1994012159-A1 | SUPPORTED LIQUID MEMBRANE DELIVERY DEVICES | PFIZER INC. (US) | 1994-06-09 | — | — | WO | disclosed |
| US-5191074-A | β-lactam compounds and production process thereof | Tamura, Yasumitsu (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0282241-B1 | BETA-LACTAM COMPOUNDS AND PRODUCTION PROCESS THEREOF | Tamura, Yasumitsu (JP) | 1991-08-14 | — | — | EP | disclosed |
| EP-0282241-A1 | Beta-lactam compounds and production process thereof | Tamura, Yasumitsu (JP) | 1988-09-14 | — | — | EP | disclosed |